Jay Feingold - 03 Jan 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Chief Medical Officer
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Jay Feingold
Issuer symbol
PYXS
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
03 Jan 2023, 18:38:18 UTC
Previous filing
15 Apr 2022
Next filing
28 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +53,931 +12% $0.000000 520,542 03 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest on April 13, 2023, subject to the Reporting Person's continued employment through the vesting date.